ClearMind’s (CMND) MEAI and Reducing Alcohol Use.
Amazing New Technologies Keep Popping up.
We love when this happens during Sector Bear Markets, which Psychedelics have...
Psychedelics CURED My Alcoholism
RELATED: Matthew Perry Reveals he Spent About $9M Trying to get Sober.
Psychedelics CURED...
Cybin (CYBN) Announces Unprecedented Positive Phase 2 Data After Single Dose.
Conference call to discuss CYB003 interim results today, November 1, 2023 at 11:00 a.m. ET
Psycheceutial Biosciences (BWVI) Listed on WeFunder!
Psycheceutical’s Psychedelic Experience, a Safer More Viable Choice in Getting Treated.
Imagine the benefits of psychedelics, without hallucinating!
PharmaTher (PHRRF) Breaks Above Resistance.
We're now up 325% in just Under a Year. Last "big" News was Receiving a Priority Original Abbreviated New Drug Application,...
Pharmather (PHRRF) Has Officially Broken Out.
Read Corporate Presentation Today.
Pharmather (PHRRF) which we gave a 'heads-up,' because looked like it was about to break...
MindMed (MNMD) IPO on Nasdaq: Becomes Second Public Psychedelic Company.
InvestmentU
By Amber Deter
Apr 27, 2021 at 12:55PM
The MindMed IPO is making...
Psychedelic Investor Conferences.
Not Quite as Popular as the Bitcoin 2021 Conference Attended by 12,000 - But Worth Considering!
Ehave (EVVHF) Hires Institutional Review Board (IRB) As It Solidifies Partnership With Tristar Wellness...
Institutional Review Board (IRB) reviews proposed research protocols to protect human subjects involved in research.
MIAMI, July 09,...
Ehave (EHVVF) Looks to Power the Psychedelics Revolution
Mental illness will cost the global economy $16 trillion by 2030 due to early-onset and lost productivity, with an estimated 12 billion working days...
Latest article
We’re in Tampa for the Kentucky Derby.
GeoVax (GOVX), Sees a Little Volume.
Normally, we get a little nervous when one of the companies we...
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
